Horse Sweet Itch Management and Welfare

Sweet itch is a chronic allergic skin condition affecting a significant proportion of UK horses and ponies. Effective management is essential for welfare of affected animals.

Key Facts

Sweet itch (also called summer seasonal recurrent dermatitis, SSRD) is caused by hypersensitivity to Culicoides midge bites
An estimated 3-5% of UK horses and ponies suffer from sweet itch - up to 60% of some pony breeds
Affected horses show intense itching particularly along the mane and tail, causing self-trauma and hair loss
Management includes sweet itch rugs covering vulnerable areas, stabling at dawn and dusk when midges are most active, and insect repellents
Omalizumab (a biological agent) has shown promising results in clinical trials as a disease-modifying treatment
Poor management of sweet itch causes significant chronic suffering through constant itch, sleep disruption, and skin damage
Climate change is extending the UK Culicoides midge season, potentially increasing sweet itch severity and duration

Welfare Considerations

Sweet itch welfare is a chronic pain and discomfort management challenge. Affected horses live with intense, constant itching during the midge season - experienced as severe itch rather than pain but nonetheless profoundly disruptive to wellbeing. Horses that rub aggressively damage their skin, creating secondary infections that add further discomfort. Management requires year-round vigilance and significant investment in protective rugs, stabling modifications, and potentially veterinary treatments. Without adequate management, sweet itch horses live through months of significant suffering each year that is entirely preventable with appropriate care.

What You Can Do

Invest in well-fitting sweet itch rugs for affected horses before the midge season begins
Stable sweet itch horses at dawn and dusk to reduce midge exposure during peak biting periods
Apply appropriate insect repellents to exposed areas not covered by rugs
Discuss emerging treatments including omalizumab with your vet if conventional management is providing insufficient relief